Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02557191 · ClinicalTrials.gov registry record
Biomarkers, Neurodevelopment and Preterm Infants
A clinical trial, sponsored by Montefiore Medical Center.
- Terminated
- Registry status
- 4
- Enrollment target
NCT02557191 is a clinical trial that was terminated before completion, run by Montefiore Medical Center. The registered enrollment target is 4 participants.
The verdict
NCT02557191 was terminated before completion, sponsored by Montefiore Medical Center.
- TERMINATED
- Registry status
- 4 participants
- Enrollment target
Study Summary
Approximately 2% of neonates in the US are born very preterm. Preterm births are associated with impaired cognitive, language and motor function, and increased risk for autism spectrum disorders. Epidemiological studies indicate a dose-response relationship between gestational age at delivery and cognitive impairments, with the most immature of newborns being the most susceptible to developmental delays. Sensitive and reproducible biomarkers of long-term neurocognitive impairments are currently lacking. The investigators seek to identify epigenetic markers that mediate the relationship between adverse prematurity-related exposures and neurocognitive impairments. The overarching hypothesis of this proposal is that DNA methylation profiles of CD34+ hematopoetic progenitor and stem cells from very preterm infants can be used as a risk-stratifying biomarker for predicting neurocognitive impairment in childhood.
Interventions
- OTHER Observational study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2015-04 |
| Est. Completion | 2018-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02557191
The ClinicalTrials.gov registry entry for NCT02557191 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Observational study is the first listed.
NCT02557191 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02557191 about?
NCT02557191 is a clinical study titled "Biomarkers, Neurodevelopment and Preterm Infants". Approximately 2% of neonates in the US are born very preterm. Preterm births are associated with impaired cognitive, language and motor function, and increased risk for autism spectrum disorders. Epidemiological studies indicate a dose-response relationship between gestational age at delivery and co...
What is the current status of trial NCT02557191?
This trial is currently terminated. The enrollment target is 4 participants. The study started on 2015-04. Estimated completion is 2018-12.
What interventions are being tested in trial NCT02557191?
The interventions under investigation include: Observational study (OTHER).
Who is sponsoring clinical trial NCT02557191?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.